Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+11.88%
+0.26%
-6.73%
-24.71%
+0.63%
AFMD
Affimed N.V.
$0.70
Chart
0.78
1.06
1.29
4.71
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+11.88%
+0.26%
-6.73%
-24.71%
+0.63%
AFMD
Affimed N.V.
$0.70
Chart
0.78
1.06
1.29
4.71
AFMD Latest Headlines
Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting.
Tue Apr 29, 2025
Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting. ®) acimtamig in combination with AlloNK® (AB-101) has been accepted for an oral presentation at the Annual Meeting of the American Society for Clinical Oncology (ASCO) taking place May 30 – June 3 2025 in Chicago Illinois. In addition two abstracts on AFM24 in combination with atezolizumab in non-small cell lung cancer (NSCLC) have been accepted as poster presentations.
Wed Apr 23, 2025
Affimed Gets NASDAQ Notice For Non-Compliance With $1 Minimum Bid Price Requirement . (RTTNews) - Affimed N.V. (AFMD) on Monday announced that it received a deficiency notice from the NASDAQ Stock Market on April 15 2025 indicating that the company is not in compliance with the minimum $1.00 bid price requirement for continued listing on the Nasdaq Global Select
Mon Apr 21, 2025
Affimed receives Nasdaq non-compliance notice.
Mon Apr 21, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
AFMD Stock trends
AFMD Stock performance
AFMD Stock analysis
AFMD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Login to display Affimed N.V. (AFMD) recommendation from the last 90 days from financial news and social media.
Hover over the category for more information
